Skip to main content
MSGP logo

MedSmart Group Inc. (MSGP) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0006 $0.00 (0.00%)
Vol: 5.9K| 52-wk range: $0.0001 – $0.0021
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

MedSmart Group Inc. (MSGP) trades at $0.0006. MedSmart Group Inc. operates a network of wellness centers specializing in anti-aging treatments. The company offers a range of services, including hormone restoration, cryogen therapy, and cosmetic procedures. Sector: Healthcare.

Price as of · Last analyzed: Mar 16, 2026
MedSmart Group Inc. operates a network of wellness centers specializing in anti-aging treatments. The company offers a range of services, including hormone restoration, cryogen therapy, and cosmetic procedures.

Analyst Coverage for MSGP: MSGP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the MSGP film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

MedSmart Group Inc. (MSGP) Healthcare & Pipeline Overview

Employees4
HeadquartersBay Harbor Islands, United States

MedSmart Group Inc. operates wellness centers providing anti-aging treatments like hormone therapy and cosmetic procedures. Focusing on personalized wellness, the company competes in the fragmented medical care facilities sector, facing challenges in scaling its service-based business model and navigating regulatory landscapes.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for MSGP?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

MedSmart Group Inc. presents a speculative investment opportunity given its focus on the growing anti-aging market. However, its financial viability is questionable, considering its negative P/E ratio of -0.34 and lack of dividend yield. The company's success hinges on its ability to effectively market its services, expand its network of wellness centers, and maintain a competitive edge in a fragmented market. The beta of -80.68 indicates an inverse correlation with the market, which may be a statistical anomaly due to the stock's low liquidity and trading volume. Investors should carefully consider the risks associated with OTC-traded companies and the limited financial information available.

Based on FMP financials and quantitative analysis

MSGP Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Operates a network of MedSmart wellness centers specializing in anti-aging treatments.

  • Offers a range of services including hormone restoration, cryogen therapy, and cosmetic procedures.
  • Based in Bay Harbor Islands, Florida, indicating a regional focus.
  • P/E ratio of -0.34 suggests the company is currently not profitable.
  • Beta of -80.68 indicates an inverse correlation with the market, though this may be skewed due to low liquidity.

Who Are MSGP's Competitors?

MSGP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
MNDR Mobile-health Network Solutions Class A Ordinary Shares $1.32 +3.94% —
CCM Concord Medical Services Holdings Limited $3.17 +7.82% —
PIII P3 Health Partners Inc. $6.36 +1.44% $20.8M —
DCGO DocGo Inc. $0.37 -6.27% $36.5M —
BTMD biote Corp. $1.15 -0.86% $50.7M 67 5-pillar
JYNT The Joint Corp. $7.28 -2.54% $104M 70 5-pillar
AIRS AirSculpt Technologies, Inc. $1.77 +4.12% $125M 32 5-pillar
AUNA Auna S.A. $5.06 +1.61% $375M 70 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MSGP's Key Strengths?

Specialized in anti-aging treatments.

  • Offers a diverse range of services.
  • Established network of wellness centers.
  • Experienced medical professionals.

What Are MSGP's Weaknesses?

Limited financial resources.

  • Small number of employees.
  • Geographic concentration in Florida.
  • Reliance on specific treatments.

What Are the Key Risks for MSGP?

Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.

  • Intense competition from other wellness centers and medical spas.
  • Changes in regulations and healthcare policies affecting the anti-aging industry.
  • Economic downturn affecting consumer spending on non-essential treatments.
  • Negative publicity or lawsuits related to the safety or efficacy of treatments.
  • Low liquidity and high price volatility due to OTC listing.

What Are MSGP's Competitive Advantages?

  • Established network of MedSmart wellness centers.
  • Specialized expertise in anti-aging treatments.
  • Proprietary treatment protocols or programs (if any).
  • Brand recognition in local markets (if any).

What Does MSGP Do?

MedSmart Group Inc., established in 2004 and based in Bay Harbor Islands, Florida, owns and operates MedSmart wellness centers. These centers specialize in anti-aging treatments, catering to individuals seeking to improve their overall well-being and appearance. The company's service offerings include a diverse range of treatments, such as testosterone replacement therapy, cryogen therapy, hormone restoration, and treatments for conditions like hypothyroidism, allergies, high cholesterol, hypertension, and diabetes. MedSmart also provides weight management programs like the Smart Diet and Medi-Fast program, alongside cosmetic procedures including vein treatment, laser hair removal, and hair loss treatment. Additionally, the company addresses specific concerns like erectile dysfunction. MedSmart Group Inc. aims to provide comprehensive anti-aging solutions through its network of wellness centers, operating within the competitive medical care facilities sector.

What Products and Services Does MSGP Offer?

  • Owns and operates a network of MedSmart wellness centers.
  • Specializes in anti-aging treatments.
  • Offers testosterone replacement therapy.
  • Provides cryogen therapy.
  • Offers hormone restoration treatments.
  • Treats conditions like hypothyroidism, allergies, high cholesterol, hypertension, and diabetes.
  • Provides weight management programs.
  • Offers cosmetic procedures like vein treatment and laser hair removal.

How Does MSGP Make Money?

  • Generates revenue by providing anti-aging treatments and wellness services at its MedSmart centers.
  • Revenue streams include fees for services like hormone therapy, cryogen therapy, and cosmetic procedures.
  • May offer membership programs or packages for recurring treatments.

What Industry Does MSGP Operate In?

MedSmart Group Inc. operates within the medical care facilities industry, which is experiencing growth driven by an aging population and increased demand for preventative and cosmetic treatments. The anti-aging market, in particular, is expanding, with consumers seeking solutions to maintain their health and appearance. However, the industry is highly competitive and fragmented, with numerous independent clinics and larger chains vying for market share. MedSmart faces competition from established players and must differentiate itself through specialized services, effective marketing, and a strong customer experience.

Who Are MSGP's Key Customers?

  • Individuals seeking anti-aging treatments and wellness services.
  • Customers interested in hormone restoration, weight management, and cosmetic procedures.
  • Patients with conditions like hypothyroidism, allergies, high cholesterol, hypertension, and diabetes seeking specialized treatments.
Model self-rating on this text: 67% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage
F-Score 1/9

Financial Health

MedSmart Group Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

ROE 27%

Key Financial Metrics

Return on equity for MedSmart Group Inc. stands at 26.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -10.1%, showing how much profit it generates from its asset base. A current ratio of 0.28 means current liabilities exceed short-term assets, a liquidity point worth watching.

Company Profile

MedSmart Group Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Bay Harbor Islands, US. The company is led by CEO Adel Nasser. MSGP has traded publicly since 2005.

MSGP Financials

Fundamental Snapshot

Return on Equity (TTM)
+26.8%
Current Ratio
0.3
EV/EBITDA (TTM)
14.4

Based on FMP financials and quantitative analysis

MSGP Latest News

No recent news available for MSGP.

MSGP Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MSGP.

Price Targets

Wall Street price target analysis for MSGP.

MSGP MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MSGP; grades run from A+ (80-100) to F (below 30).

MSGP OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that MedSmart Group Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it difficult for investors to assess their financial health and performance. Investing in OTC Other stocks carries significant risks due to the lack of regulation and transparency compared to stocks listed on major exchanges like the NYSE or NASDAQ.

  • OTC Tier: OTC Other
Liquidity: Liquidity for MSGP is likely very low due to its OTC Other listing. This can result in wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. Investors may experience significant price volatility and may not be able to easily exit their positions. Trading volume is likely minimal, further exacerbating liquidity issues.
OTC Risk Factors:
  • Limited financial disclosure.
  • Low liquidity and high price volatility.
  • Potential for fraud or manipulation.
  • Lack of regulatory oversight.
  • Going concern risk.
Due Diligence Checklist:
  • Verify the company's registration and compliance with regulatory requirements.
  • Obtain and review the company's financial statements, if available.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's management team and their track record.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before making any investment decisions.
Legitimacy Signals:
  • Company has been in operation since 2004.
  • Operates a network of wellness centers.
  • Offers a range of anti-aging treatments.
  • Headquartered in Bay Harbor Islands, Florida.

What Investors Ask About MedSmart Group Inc. (MSGP) — Healthcare

What do analysts say about MSGP stock?

There is currently no available analyst coverage or consensus on MedSmart Group Inc. (MSGP) stock. The company trades on the OTC market, and information is limited. Due to the lack of analyst ratings and financial data, it is difficult to assess the stock's valuation and growth potential.

What are the main risks for MSGP?

MedSmart Group Inc. faces several risks, including intense competition from other wellness centers and medical spas. Changes in regulations and healthcare policies could also impact the company's business.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial information available for MedSmart Group Inc.
  • OTC market stocks are inherently riskier than exchange-listed stocks.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis